Product image of Nadiclox (Fusidic Acid) supplied by GNH India

Nadiclox

Active Ingredient:
Fusidic Acid
Origin:
EU

Nadiclox (Fusidic Acid)

Fusidic Acid, the active ingredient in Nadiclox, is an antibiotic presented as a topical preparation for skin use. It is employed to treat bacterial skin infections, particularly those caused by Staphylococcus aureus, and is applied directly to the affected area.

GNH India supplies Nadiclox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the supply chain.

Manufacturer / TM Owner

Laboratório Medinfar - Produtos Farmacêuticos, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nadiclox, containing fusidic acid, is used to treat bacterial skin conditions where Staphylococcus aureus is implicated.

  • Impetigo: reduces bacterial load and promotes healing of superficial skin lesions.
  • Folliculitis: treats infection of hair follicles caused by Staphylococcus aureus.
  • Secondary bacterial infection of eczema: controls infection and limits spread of lesions.

How It Works

  • Fusidic acid inhibits bacterial protein synthesis by binding to elongation factor G (EF‑G) on the ribosome, preventing the translocation step of peptide chain elongation. This blockade halts bacterial growth, rendering the organism bacteriostatic against susceptible Gram‑positive organisms, especially Staphylococcus aureus.

Side Effects

Topical application of fusidic acid may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects

  • Skin irritation: mild redness or discomfort at the application site.
  • Itching: localized pruritus following use.
  • Burning sensation: transient heat feeling on the skin.
  • Dryness: reduced skin moisture where applied.

Serious or Rare Side Effects

  • Allergic reaction: including urticaria, angioedema, or anaphylaxis.
  • Severe skin necrosis: extensive tissue death at the site.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis: life‑threatening mucocutaneous reactions.
  • Systemic hypersensitivity: rare generalized immune response.

Precautions & Warnings

When using Nadiclox, clinicians should observe the following precautions to ensure safety and effectiveness.

  • Assess allergy history: verify no prior hypersensitivity to fusidic acid or related antibiotics.
  • Limit duration of use: avoid prolonged application beyond the prescribed period.
  • Avoid use on large surface areas: minimize systemic absorption risk.
  • Do not apply to mucous membranes or eyes: product is intended for skin only.
  • Avoid use on compromised skin barrier unless directed: damaged skin may increase irritation.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Fusidic acid can interact with other topical or systemic agents; awareness of these interactions helps optimize therapy.

Major Interactions (Avoid)

  • Systemic antibiotics (e.g., macrolides): may reduce fusidic acid efficacy.
  • Topical corticosteroids: can antagonize antibacterial effect.
  • Other topical antibiotics: increased risk of resistance development.

Moderate Interactions (Monitor Closely)

  • Antifungal agents: possible reduced activity when used concurrently.
  • Skin care products containing alcohol: may increase local irritation.
  • Phototoxic agents: may heighten skin sensitivity to light.

Frequently Asked Questions

Nadiclox is a topical formulation containing fusidic acid that is used to treat bacterial skin infections, especially those caused by Staphylococcus aureus such as impetigo, folliculitis, and secondary infections of eczema.

Fusidic acid blocks bacterial protein synthesis by binding to elongation factor G on the ribosome, preventing the translocation step of peptide chain elongation. This stops bacterial growth, making it effective against susceptible Gram‑positive organisms.

The prescribed amount and frequency of Nadiclox are determined by the treating clinician based on the infection type, severity, and patient factors. Patients should follow the healthcare professional’s instructions and not alter the regimen on their own.

Safety data for fusidic acid in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against risks and consider alternative treatments when appropriate. Women who are pregnant or nursing should discuss use with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Nadiclox (fusidic acid) offers a narrow‑spectrum activity primarily against Staphylococcus aureus, which can reduce disruption of normal skin flora compared with broader agents like mupirocin. It is often chosen for infections where resistance to other topical antibiotics is a concern.

Store Nadiclox at room temperature, below 25 °C, in its original packaging. Protect it from moisture, excessive heat and direct sunlight. Keep the container tightly closed when not in use to maintain product stability.

Nadiclox is applied directly to the affected skin area, usually in a thin layer, after gentle cleansing. The exact frequency and duration are set by the prescriber, typically ranging from once to several times daily for a limited period.

Serious adverse reactions, though rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and extensive skin necrosis. Immediate medical attention is required if signs of a severe reaction appear.

Patients with a known hypersensitivity to fusidic acid or any component of the formulation should avoid using Nadiclox. It is also contraindicated on mucous membranes, eyes, and on large areas of damaged skin unless specifically directed by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fusidic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT